What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
Identifieur interne : 001484 ( Ncbi/Merge ); précédent : 001483; suivant : 001485What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
Auteurs : Janet E. PopeSource :
- Current Treatment Options in Rheumatology [ 2198-6002 ] ; 2020.
Abstract
The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment, whether they should stop their advanced therapies, if they will have a worse outcome if/when infected due to their underlying medication condition(s) and if they will have drug availability, especially with press (without much data) coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases.
Preliminarily, articles seem to suggest that patients with rheumatic diseases may not have more infections from SARS-CoV-2 and similar outcomes to age and gender matched patients, but fear of rheumatic medications increasing their risk, drug shortages, and work exposure all are concerns for patients.
The long term effects of the pandemic in patients with rheumatic diseases will not be known until much later and likely include stressors flaring disease (fear, illness, job loss, social isolation), post-traumatic stress, flaring due to stopping medications, less physician visits with subsequent under-treatment, and increases in chronic concomitant fatigue, pain, fibromyalgia.
Url:
DOI: 10.1007/s40674-020-00145-y
PubMed: NONE
PubMed Central: 7191545
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000145
- to stream Pmc, to step Curation: 000145
- to stream Pmc, to step Checkpoint: 000010
Links to Exploration step
PMC:7191545Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What Does the COVID-19 Pandemic Mean for Rheumatology Patients?</title>
<author><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E." last="Pope">Janet E. Pope</name>
<affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id>
<institution>Schulich School of Medicine & Dentistry,</institution>
</institution-wrap>
London, ON Canada</nlm:aff>
<wicri:noCountry code="subfield">ON Canada</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id>
<institution>Western University,</institution>
</institution-wrap>
London, ON Canada</nlm:aff>
<wicri:noCountry code="subfield">ON Canada</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.416448.b</institution-id>
<institution-id institution-id-type="ISNI">0000 0000 9674 4717</institution-id>
<institution>Department of Medicine, Division of Rheumatology,</institution>
<institution>St Joseph’s Health Care,</institution>
</institution-wrap>
268 Grosvenor St., London, ON N6A 4V2 Canada</nlm:aff>
<wicri:noCountry code="subfield">ON N6A 4V2 Canada</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmc">7191545</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191545</idno>
<idno type="RBID">PMC:7191545</idno>
<idno type="doi">10.1007/s40674-020-00145-y</idno>
<idno type="pmid">NONE</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">000145</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000145</idno>
<idno type="wicri:Area/Pmc/Curation">000145</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000145</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000010</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000010</idno>
<idno type="wicri:Area/Ncbi/Merge">001484</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">What Does the COVID-19 Pandemic Mean for Rheumatology Patients?</title>
<author><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E." last="Pope">Janet E. Pope</name>
<affiliation><nlm:aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id>
<institution>Schulich School of Medicine & Dentistry,</institution>
</institution-wrap>
London, ON Canada</nlm:aff>
<wicri:noCountry code="subfield">ON Canada</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="Aff2"><institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id>
<institution>Western University,</institution>
</institution-wrap>
London, ON Canada</nlm:aff>
<wicri:noCountry code="subfield">ON Canada</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="Aff3"><institution-wrap><institution-id institution-id-type="GRID">grid.416448.b</institution-id>
<institution-id institution-id-type="ISNI">0000 0000 9674 4717</institution-id>
<institution>Department of Medicine, Division of Rheumatology,</institution>
<institution>St Joseph’s Health Care,</institution>
</institution-wrap>
268 Grosvenor St., London, ON N6A 4V2 Canada</nlm:aff>
<wicri:noCountry code="subfield">ON N6A 4V2 Canada</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Current Treatment Options in Rheumatology</title>
<idno type="eISSN">2198-6002</idno>
<imprint><date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec><title>Purpose of review</title>
<p id="Par1">The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment, whether they should stop their advanced therapies, if they will have a worse outcome if/when infected due to their underlying medication condition(s) and if they will have drug availability, especially with press (without much data) coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases.</p>
</sec>
<sec><title>Recent findings</title>
<p id="Par200">Preliminarily, articles seem to suggest that patients with rheumatic diseases may not have more infections from SARS-CoV-2 and similar outcomes to age and gender matched patients, but fear of rheumatic medications increasing their risk, drug shortages, and work exposure all are concerns for patients.</p>
</sec>
<sec><title>Recent findings</title>
<p id="Par201">The long term effects of the pandemic in patients with rheumatic diseases will not be known until much later and likely include stressors flaring disease (fear, illness, job loss, social isolation), post-traumatic stress, flaring due to stopping medications, less physician visits with subsequent under-treatment, and increases in chronic concomitant fatigue, pain, fibromyalgia.</p>
</sec>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct><analytic><author><name sortKey="Raoult, D" uniqKey="Raoult D">D Raoult</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="review-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Treatm Opt Rheumatol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Treatm Opt Rheumatol</journal-id>
<journal-title-group><journal-title>Current Treatment Options in Rheumatology</journal-title>
</journal-title-group>
<issn pub-type="epub">2198-6002</issn>
<publisher><publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta><article-id pub-id-type="pmc">7191545</article-id>
<article-id pub-id-type="publisher-id">145</article-id>
<article-id pub-id-type="doi">10.1007/s40674-020-00145-y</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Hot Topic</subject>
</subj-group>
</article-categories>
<title-group><article-title>What Does the COVID-19 Pandemic Mean for Rheumatology Patients?</article-title>
</title-group>
<contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Pope</surname>
<given-names>Janet E.</given-names>
</name>
<degrees>MD, MPH, FRCPC</degrees>
<address><email>janet.pope@sjhc.london.on.ca</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label>
<institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id>
<institution>Schulich School of Medicine & Dentistry,</institution>
</institution-wrap>
London, ON Canada</aff>
<aff id="Aff2"><label>2</label>
<institution-wrap><institution-id institution-id-type="GRID">grid.39381.30</institution-id>
<institution-id institution-id-type="ISNI">0000 0004 1936 8884</institution-id>
<institution>Western University,</institution>
</institution-wrap>
London, ON Canada</aff>
<aff id="Aff3"><label>3</label>
<institution-wrap><institution-id institution-id-type="GRID">grid.416448.b</institution-id>
<institution-id institution-id-type="ISNI">0000 0000 9674 4717</institution-id>
<institution>Department of Medicine, Division of Rheumatology,</institution>
<institution>St Joseph’s Health Care,</institution>
</institution-wrap>
268 Grosvenor St., London, ON N6A 4V2 Canada</aff>
</contrib-group>
<pub-date pub-type="epub"><day>30</day>
<month>4</month>
<year>2020</year>
</pub-date>
<fpage>1</fpage>
<lpage>4</lpage>
<permissions><copyright-statement>© Springer Nature Switzerland AG 2020</copyright-statement>
<license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1"><sec><title>Purpose of review</title>
<p id="Par1">The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment, whether they should stop their advanced therapies, if they will have a worse outcome if/when infected due to their underlying medication condition(s) and if they will have drug availability, especially with press (without much data) coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases.</p>
</sec>
<sec><title>Recent findings</title>
<p id="Par200">Preliminarily, articles seem to suggest that patients with rheumatic diseases may not have more infections from SARS-CoV-2 and similar outcomes to age and gender matched patients, but fear of rheumatic medications increasing their risk, drug shortages, and work exposure all are concerns for patients.</p>
</sec>
<sec><title>Recent findings</title>
<p id="Par201">The long term effects of the pandemic in patients with rheumatic diseases will not be known until much later and likely include stressors flaring disease (fear, illness, job loss, social isolation), post-traumatic stress, flaring due to stopping medications, less physician visits with subsequent under-treatment, and increases in chronic concomitant fatigue, pain, fibromyalgia.</p>
</sec>
</abstract>
<kwd-group xml:lang="en"><title>Keywords</title>
<kwd>COVID-19</kwd>
<kwd>Rheumatology</kwd>
<kwd>Rheumatologists</kwd>
<kwd>Coronavirus</kwd>
<kwd>Pandemic</kwd>
<kwd>Drug shortages</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
<affiliations><list></list>
<tree><noCountry><name sortKey="Pope, Janet E" sort="Pope, Janet E" uniqKey="Pope J" first="Janet E." last="Pope">Janet E. Pope</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001484 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001484 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= StressCovidV1 |flux= Ncbi |étape= Merge |type= RBID |clé= PMC:7191545 |texte= What Does the COVID-19 Pandemic Mean for Rheumatology Patients? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:NONE" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a StressCovidV1
This area was generated with Dilib version V0.6.33. |